Ventyx Biosciences Inc (VTYX) Stock Analysis

Ventyx Biosciences Inc (VTYX) is a publicly traded company in the HEALTHCARE sector. It trades at $14.00. This page summarizes the public market data, fundamentals, and frequently asked questions for VTYX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $14.00

Market Sentiment

Ventyx Biosciences Inc currently has a Neutral sentiment score of 0.07.

About Ventyx Biosciences Inc

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Encinitas, California, dedicated to developing novel small molecule therapeutics for inflammatory and autoimmune disorders. The company is advancing a promising pipeline of drug candidates that target critical pathways involved in these diseases, aiming to meet substantial unmet medical needs. With a robust emphasis on research and development, Ventyx is well-positioned to provide innovative treatment solutions th...

GNG Research Analysis

GNG Research scores Ventyx Biosciences Inc (VTYX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VTYX.

Frequently Asked Questions

Does VTYX pay dividends?

Ventyx Biosciences Inc (VTYX) does not currently pay a regular dividend.